4
Changes in Ownership
TransMedics Group, Inc. Filed Acc 0000950170-23-005194
Director sold 5,934 shares at an average $76.69 ($455,100)
- Director acquired 5,934 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Weill David Director | 2023-02-27 | Option exercise | +5,934 | $14.20 | $84,263 | 15,934 | D: show line 1 in the form |
| Weill David Director | 2023-02-27 | Sale | −964 | $77.64 | $74,845 | 14,970 | D: show line 2 in the form |
| Weill David Director | 2023-02-27 | Sale | −4,970 | $76.51 | $380,255 | 10,000 | D: show line 3 in the form |
| Open-market sales · 5,934 sh · avg $76.69 · $455,100 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Weill David Director | 2023-02-27 | Option exercise · Stock Option (Right to Buy) | −5,934 | 10,000 | D: show line 4 in the form |
Loading xslF345X03/ownership.xml…